Caribou Biosciences, Inc.

NASDAQ:CRBU

Biotechnology

Healthcare
$0.49 -2.74%

-$0.05 today

Market cap
$52.47M
Beta
2.33
P/E (TTM)
-1.1
EPS (TTM)
-$1.39
52W Low $1.20High $3.54

Volume 1.01M

Average 1.83M

Income Statement

Follow revenue through to earnings.

Revenue

$11.16M

FY 2025 · Annual

+11.7% YoY

Operating Income

-$136.19M

FY 2025 · Annual

Net Income

-$148.13M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.6M13.85M34.48M9.99M11.16M
Cost of Revenue984K3.64M3.53M3.93M3.65M
Gross Profit8.61M10.21M30.95M6.07M7.51M
Gross Margin89.7%73.7%89.8%60.7%67.3%
Research & Development52.26M82.23M112.08M130.15M109.44M
Selling, General & Admin23.34M38.02M38.46M46.46M37.91M
Operating Expenses75.59M116.61M147.01M172.68M143.71M
Depreciation & Amortization984K3.64M3.53M3.93M3.65M
EBITDA(65.61M)(95.71M)(98.35M)(145.19M)(145.03M)
EBITDA Margin-683.6%-691.0%-285.3%-1452.7%-1299.7%
Operating Income(66.98M)(106.4M)(116.06M)(166.62M)(136.19M)
Operating Margin-697.8%-768.2%-336.6%-1667.2%-1220.5%
Interest Income148K4.6M10.7M08M
Interest Expense8K0000
Other Income / Expenses377K7.05M14.18M17.5M(12.48M)
Income Before Tax(66.6M)(99.35M)(101.88M)(149.11M)(148.68M)
Pre-Tax Margin-693.9%-717.3%-295.5%-1492.0%-1332.3%
Income Tax Expense321K70K193K(9K)(550K)
Net Income(66.92M)(99.42M)(102.07M)(149.11M)(148.13M)
Net Margin-697.3%-717.8%-296.1%-1491.9%-1327.4%
EPS (Basic)(1.11)(1.64)(1.38)(1.65)(1.59)
EPS (Diluted)(1.11)(1.64)(1.38)(1.65)(1.59)
Weighted Avg Shares60.26M60.8M73.81M90.32M93.39M
Weighted Avg Shares (Diluted)60.26M60.8M73.81M90.32M93.39M

CRBU Earnings Waterfall · TTM

NASDAQ:CRBU · Revenue to Net Income

Key Ratios

EPS$-1.42
Gross Margin81.1%
Net Margin-1250.1%
P/E Ratio-1.4
P/S Ratio64.2

Analysis

$11.2M of revenue converted into -$133.2M of net income for the selected period. Gross margin is 81.1% and net margin is -1250.1%, showing how much revenue survives after costs and taxes. EPS is $-1.42, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 6, 2026
8-KCurrent reportAug 13, 2026
10-QQuarterly reportAug 13, 2026
SC 13GSC 13G filingJul 27, 2026
8-KCurrent reportJun 18, 2026

How much revenue does CRBU generate?

Caribou Biosciences, Inc. (CRBU) reported $11.16M of revenue in fiscal 2025.

Is CRBU profitable?

Caribou Biosciences, Inc. (CRBU) reported -$148.13M of net income, with a net margin of -1327.4%.